StonvexLoading…
StonvexStonvexStonvexCore line items from AMT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $216.10M | $935.90M | $716.10M | $469.70M |
Operating Income | $1.24B | $4.85B | $3.69B | $2.45B |
Net Income | $878.50M | $2.63B | $1.79B | $879.10M |
EPS (Diluted) | $1.84 | $5.40 | $3.64 | $1.83 |
Total Assets | $63.23B | $63.19B | $63.89B | $63.75B |
Total Liabilities | $53.08B | $52.84B | $53.12B | $53.28B |
Cash & Equivalents | $1.61B | $1.47B | $1.95B | $2.08B |
Free Cash Flow OCF − CapEx | $951.10M | $3.78B | $2.94B | $1.94B |
Shares Outstanding | 465.99M | 466.32M | 468.29M | 468.22M |